Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 171 articles:
HTML format
Text format



Single Articles


    October 2018
  1. ANSTETT K, Brenner B, Mesplede T, Wainberg MA, et al
    Correction for Anstett et al., "HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity".
    J Virol. 2018;92.
    PubMed     Text format    


  2. SOARE AY, Durham ND, Gopal R, Tweel B, et al
    P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1beta in a human tonsil explant model.
    J Virol. 2018 Oct 10. pii: JVI.01186-18. doi: 10.1128/JVI.01186.
    PubMed     Text format     Abstract available


  3. HOANG TN, Harper JL, Pino MC, Wang H, et al
    Bone marrow-derived CD4(+) T cells are depleted in SIV-infected macaques and contribute to the size of the replication competent reservoir on ART.
    J Virol. 2018 Oct 10. pii: JVI.01344-18. doi: 10.1128/JVI.01344.
    PubMed     Text format     Abstract available


  4. HARGETT AA, Wei Q, Knoppova B, Hall S, et al
    Defining HIV-1 Envelope N-glycan Microdomains Through Site-specific Heterogeneity Profiles.
    J Virol. 2018 Oct 10. pii: JVI.01177-18. doi: 10.1128/JVI.01177.
    PubMed     Text format     Abstract available


  5. KINLOCH NN, Lee GQ, Carlson JM, Jin SW, et al
    Genotypic and Mechanistic Characterization of Subtype-specific HIV Adaptation to Host Cellular Immunity.
    J Virol. 2018 Oct 10. pii: JVI.01502-18. doi: 10.1128/JVI.01502.
    PubMed     Text format     Abstract available


    September 2018
  6. STAEHELI P, Haller O
    Human MX2/MxB: a potent interferon-induced post-entry inhibitor of herpesviruses and HIV-1.
    J Virol. 2018 Sep 26. pii: JVI.00709-18. doi: 10.1128/JVI.00709.
    PubMed     Text format     Abstract available


  7. DOMINGUEZ-MOLINA B, Machmach K, Perales C, Tarancon-Diez L, et al
    Toll Like Receptor-7 and -9 agonists improve Hepatitis C Virus replication and infectivity inhibition by plasmacytoid dendritic cells.
    J Virol. 2018 Sep 19. pii: JVI.01219-18. doi: 10.1128/JVI.01219.
    PubMed     Text format     Abstract available


  8. MACDUFF DA, Baldridge MT, Qaqish AM, Nice TJ, et al
    HOIL1 is essential for the induction of type I and III interferons by MDA5 and regulates persistent murine norovirus infection.
    J Virol. 2018 Sep 12. pii: JVI.01368-18. doi: 10.1128/JVI.01368.
    PubMed     Text format     Abstract available


  9. REN Y, Korom M, Truong R, Chan D, et al
    Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs.
    J Virol. 2018 Sep 12. pii: JVI.00895-18. doi: 10.1128/JVI.00895.
    PubMed     Text format     Abstract available


  10. PISSANI F, Schulte B, Eller MA, Schultz BT, et al
    Modulation of Vaccine-induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    J Virol. 2018 Sep 12. pii: JVI.01143-18. doi: 10.1128/JVI.01143.
    PubMed     Text format     Abstract available


  11. BOEIJEN LL, Hou J, de Groen RA, Verbon A, et al
    Persistent replication of HIV, HCV and HBV results in distinct gene expression profiles by human NK cells.
    J Virol. 2018 Sep 5. pii: JVI.00575-18. doi: 10.1128/JVI.00575.
    PubMed     Text format     Abstract available


  12. KUMAR NA, McBrien JB, Carnathan DG, Mavigner M, et al
    Antibody-mediated CD4 depletion induces homeostatic CD4+ T cell proliferation without detectable virus reactivation in ART-treated SIV-infected macaques.
    J Virol. 2018 Sep 5. pii: JVI.01235-18. doi: 10.1128/JVI.01235.
    PubMed     Text format     Abstract available


  13. PAROLINI F, Biswas P, Serena M, Sironi F, et al
    Correction for Parolini et al., "Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity".
    J Virol. 2018;92.
    PubMed     Text format    


    August 2018
  14. TEODOROF-DIEDRICH C, Spector SA
    Human Immunodeficiency Virus Type-1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.
    J Virol. 2018 Aug 29. pii: JVI.00993-18. doi: 10.1128/JVI.00993.
    PubMed     Text format     Abstract available


  15. SHARMA S, Lewinski MK, Guatelli J
    An N-glycosylated form of SERINC5 is specifically incorporated into HIV-1 virions.
    J Virol. 2018 Aug 29. pii: JVI.00753-18. doi: 10.1128/JVI.00753.
    PubMed     Text format     Abstract available


  16. WELCH JL, Kaddour H, Schlievert PM, Stapleton JT, et al
    Semen exosomes promote transcriptional silencing of HIV-1 by disrupting NF-kB/Sp1/Tat circuitry.
    J Virol. 2018 Aug 15. pii: JVI.00731-18. doi: 10.1128/JVI.00731.
    PubMed     Text format     Abstract available


  17. SUTTON MS, Ellis-Connell A, Moriarty RV, Balgeman AJ, et al
    Acute-phase CD4+ T cell responses targeting invariant viral regions are associated with control of live-attenuated simian immunodeficiency virus.
    J Virol. 2018 Aug 15. pii: JVI.00830-18. doi: 10.1128/JVI.00830.
    PubMed     Text format     Abstract available


  18. RANKOVIC S, Ramalho R, Aiken C, Rousso I, et al
    PF74 reinforces the HIV-1 capsid to impair reverse transcription-induced uncoating.
    J Virol. 2018 Aug 8. pii: JVI.00845-18. doi: 10.1128/JVI.00845.
    PubMed     Text format     Abstract available


  19. CHONG H, Zhu Y, Yu D, He Y, et al
    Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against HIV-1, HIV-2, and Simian Immunodeficiency Virus.
    J Virol. 2018 Aug 8. pii: JVI.01088-18. doi: 10.1128/JVI.01088.
    PubMed     Text format     Abstract available


  20. PHILLIPS B, Van Rompay KKA, Rodriguez-Nieves J, Lorin C, et al
    Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques.
    J Virol. 2018 Aug 8. pii: JVI.01051-18. doi: 10.1128/JVI.01051.
    PubMed     Text format     Abstract available


  21. CARNES SK, Zhou J, Aiken C
    HIV-1 Engages a Dynein-Dynactin-BICD2 Complex for Infection and Transport to the Nucleus.
    J Virol. 2018 Aug 1. pii: JVI.00358-18. doi: 10.1128/JVI.00358.
    PubMed     Text format     Abstract available


  22. OSEI KUFFOUR E, Schott K, Jaguva Vasudevan AA, Holler J, et al
    USP18 (UBP43) Abrogates p21-Mediated Inhibition of HIV-1.
    J Virol. 2018 Aug 1. pii: JVI.00592-18. doi: 10.1128/JVI.00592.
    PubMed     Text format     Abstract available


  23. WANG Z, Wang W, Cui YC, Pan Q, et al
    HIV-1 employs multiple mechanisms to resist Cas9/sgRNA targeting the viral primer binding site.
    J Virol. 2018 Aug 1. pii: JVI.01135-18. doi: 10.1128/JVI.01135.
    PubMed     Text format     Abstract available


  24. ANANG S, Kaushik N, Hingane S, Kumari A, et al
    Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101.
    J Virol. 2018 Aug 1. pii: JVI.00684-18. doi: 10.1128/JVI.00684.
    PubMed     Text format     Abstract available


  25. PAN T, Peng Z, Tan L, Zou F, et al
    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Potently Inhibit the Replication of Zika Viruses by Inducing the Degradation of AXL.
    J Virol. 2018 Aug 1. pii: JVI.01018-18. doi: 10.1128/JVI.01018.
    PubMed     Text format     Abstract available


    July 2018
  26. PENNINGTON MR, Voorhees IEH, Callaway HM, Dehghanpir SD, et al
    The HIV integrase inhibitor raltegravir inhibits felid alphaherpesvirus 1 (FeHV-1) replication by targeting both DNA replication and late gene expression.
    J Virol. 2018 Jul 25. pii: JVI.00994-18. doi: 10.1128/JVI.00994.
    PubMed     Text format     Abstract available


  27. PENG BJ, Carlson JM, Liu MKP, Gao F, et al
    Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection.
    J Virol. 2018 Jul 18. pii: JVI.00711-18. doi: 10.1128/JVI.00711.
    PubMed     Text format     Abstract available


  28. SIN SH, Eason AB, Bigi R, Kim Y, et al
    Kaposi sarcoma-associated herpesvirus latency locus renders B cells hyperresponsive to secondary infections.
    J Virol. 2018 Jul 18. pii: JVI.01138-18. doi: 10.1128/JVI.01138.
    PubMed     Text format     Abstract available


  29. MILLER-NOVAK LK, Das J, Musich TA, Demberg T, et al
    Analysis of complement-mediated lysis of SIV and SIV-infected cells reveals sex differences in vaccine-induced immune responses in Rhesus macaques.
    J Virol. 2018 Jul 18. pii: JVI.00721-18. doi: 10.1128/JVI.00721.
    PubMed     Text format     Abstract available


  30. ALSAHAFI N, Anand SP, Castillo-Menendez L, Verly MM, et al
    SOSIP changes affect human immunodeficiency virus (HIV-1) envelope glycoprotein conformation and CD4 engagement.
    J Virol. 2018 Jul 18. pii: JVI.01080-18. doi: 10.1128/JVI.01080.
    PubMed     Text format     Abstract available


  31. MAVIGNER M, Habib J, Deleage C, Rosen E, et al
    SIV persistence in cellular and anatomic reservoirs in ART-suppressed infant rhesus macaques.
    J Virol. 2018 Jul 11. pii: JVI.00562-18. doi: 10.1128/JVI.00562.
    PubMed     Text format     Abstract available


  32. CHAN KW, Pan R, Costa M, Gorny MK, et al
    Structural Comparison of Human Anti-HIV-1 gp120 V3 MAbs of the Same Gene Usage Induced by Vaccination and Chronic Infection.
    J Virol. 2018 Jul 11. pii: JVI.00641-18. doi: 10.1128/JVI.00641.
    PubMed     Text format     Abstract available


  33. BUFFONE C, Martinez-Lopez A, Fricke T, Opp S, et al
    Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Translocation in Non-dividing Cells.
    J Virol. 2018 Jul 11. pii: JVI.00648-18. doi: 10.1128/JVI.00648.
    PubMed     Text format     Abstract available


  34. OJWACH DBA, MacMillan D, Reddy T, Novitsky V, et al
    Pol-driven replicative capacity impacts disease progression in HIV-1 subtype C infection.
    J Virol. 2018 Jul 11. pii: JVI.00811-18. doi: 10.1128/JVI.00811.
    PubMed     Text format     Abstract available


  35. SCHWARTZ JA, Zhang H, Ende Z, Deymier MJ, et al
    Characterization of the plasmacytoid dendritic cell response to transmitted/founder and non-transmitted variants of HIV-1.
    J Virol. 2018 Jul 11. pii: JVI.00157-18. doi: 10.1128/JVI.00157.
    PubMed     Text format     Abstract available


  36. CHIEN H, Alston CI, Dix RD
    Suppressor of Cytokine Signaling (SOCS)1 and SOCS3 Are Stimulated Within the Eye During Experimental Murine Cytomegalovirus Retinitis in Mice With Retrovirus-Induced Immunosuppression.
    J Virol. 2018 Jul 5. pii: JVI.00526-18. doi: 10.1128/JVI.00526.
    PubMed     Text format     Abstract available


  37. KHAN SN, Sok D, Tran K, Movsesyan A, et al
    Targeting the HIV-1 spike and co-receptor with bi- and trispecific antibodies for single-component broad inhibition of entry.
    J Virol. 2018 Jul 5. pii: JVI.00384-18. doi: 10.1128/JVI.00384.
    PubMed     Text format     Abstract available


  38. HOVANESSIAN AG, Soundaramourty C, Benferhat R, Le Grand R, et al
    Vaccination with the conserved caveolin-1 binding motif in HIV-1 glycoprotein gp41 delays the onset of viral infection and provides partial protection in SHIV-challenged cynomolgus macaques.
    J Virol. 2018 Jul 5. pii: JVI.00370-18. doi: 10.1128/JVI.00370.
    PubMed     Text format     Abstract available


  39. NOTO A, Procopio FA, Banga R, Suffiotti M, et al
    CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.
    J Virol. 2018 Jul 5. pii: JVI.00901-18. doi: 10.1128/JVI.00901.
    PubMed     Text format     Abstract available


  40. HEUSINGER E, Deppe K, Sette P, Krapp C, et al
    Preadaptation of SIVsmm facilitated Env-mediated counteraction of human tetherin by HIV-2.
    J Virol. 2018 Jul 5. pii: JVI.00276-18. doi: 10.1128/JVI.00276.
    PubMed     Text format     Abstract available


  41. YAN Q, Zhao R, Shen C, Wang F, et al
    Upregulation of miR-711 mediates HIV-1 Vpr promotion of KSHV latency and induction of pro-proliferative/survival cytokines by targeting the Notch/NF-kappaB signaling axis.
    J Virol. 2018 Jul 5. pii: JVI.00580-18. doi: 10.1128/JVI.00580.
    PubMed     Text format     Abstract available


    June 2018
  42. DITSE Z, Muenchhoff M, Adland E, Jooste P, et al
    HIV-1 SUBTYPE C INFECTED CHILDREN WITH EXCEPTIONAL NEUTRALIZATION BREADTH EXHIBIT POLYCLONAL RESPONSES TARGETING KNOWN EPITOPES.
    J Virol. 2018 Jun 27. pii: JVI.00878-18. doi: 10.1128/JVI.00878.
    PubMed     Text format     Abstract available


  43. SCHILLING M, Bulli L, Weigang S, Graf L, et al
    Human MxB protein is a pan-herpesvirus restriction factor.
    J Virol. 2018 Jun 27. pii: JVI.01056-18. doi: 10.1128/JVI.01056.
    PubMed     Text format     Abstract available


  44. BROCCA-COFANO E, Xu C, Wetzel KS, Cottrell ML, et al
    Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques.
    J Virol. 2018 Jun 20. pii: JVI.00576-18. doi: 10.1128/JVI.00576.
    PubMed     Text format     Abstract available


  45. XU B, Pan Q, Liang C
    The role of MxB in interferon-alpha mediated inhibition of HIV-1 infection.
    J Virol. 2018 Jun 20. pii: JVI.00422-18. doi: 10.1128/JVI.00422.
    PubMed     Text format     Abstract available


  46. MULLER JA, Glockle A, Gawanbacht A, Geyer M, et al
    Reduced Susceptibility to VIRIP-based HIV-1 Entry Inhibitors has a High Genetic Barrier and Severe Fitness Costs.
    J Virol. 2018 Jun 20. pii: JVI.00733-18. doi: 10.1128/JVI.00733.
    PubMed     Text format     Abstract available


  47. CHONG H, Xue J, Zhu Y, Cong Z, et al
    Design of Novel HIV-1/2 Fusion Inhibitors with Efficient Therapeutic Efficacy in Rhesus Monkey Models.
    J Virol. 2018 Jun 13. pii: JVI.00775-18. doi: 10.1128/JVI.00775.
    PubMed     Text format     Abstract available


  48. BALAMURUGAN A, Ng HL, Yang OO
    Cross-Reactivity Against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones.
    J Virol. 2018 Jun 13. pii: JVI.00617-18. doi: 10.1128/JVI.00617.
    PubMed     Text format     Abstract available


  49. DHARAN A, Campbell EM
    The Role of Microtubules and Microtubule Associated Proteins in HIV-1 Infection.
    J Virol. 2018 Jun 13. pii: JVI.00085-18. doi: 10.1128/JVI.00085.
    PubMed     Text format     Abstract available


  50. GURUNG S, Preno AN, Dubaut JP, Nadeau H, et al
    Translational Model of Zika Virus Disease in Baboons.
    J Virol. 2018 Jun 6. pii: JVI.00186-18. doi: 10.1128/JVI.00186.
    PubMed     Text format     Abstract available


  51. KELLER PW, Morrison O, Vassell R, Weiss CD, et al
    HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    J Virol. 2018 Jun 6. pii: JVI.00583-18. doi: 10.1128/JVI.00583.
    PubMed     Text format     Abstract available


  52. NEVOT M, Jordan-Paiz A, Martrus G, Andres C, et al
    HIV-1 Protease Evolvability is Affected by Synonymous Nucleotide Recoding.
    J Virol. 2018 Jun 6. pii: JVI.00777-18. doi: 10.1128/JVI.00777.
    PubMed     Text format     Abstract available


  53. MARTINS MA, Tully DC, Pedreno-Lopez N, von Bredow B, et al
    Mamu-B*17+ rhesus macaques vaccinated with env, vif, and nef manifest early control of SIVmac239 replication.
    J Virol. 2018 Jun 6. pii: JVI.00690-18. doi: 10.1128/JVI.00690.
    PubMed     Text format     Abstract available


    May 2018
  54. ANTONUCCI JM, Kim SH, St Gelais C, Bonifati S, et al
    SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4(+) T-cells.
    J Virol. 2018 May 23. pii: JVI.00292-18. doi: 10.1128/JVI.00292.
    PubMed     Text format     Abstract available


  55. SINGH S, Ramirez-Salazar EG, Doueiri R, Valentin A, et al
    Control of Heterologous SIVsmE660 infection by DNA and Protein Co-immunization Regimens Combined with Different Toll-like Receptor-4 (TLR-4) Based Adjuvants in Macaques.
    J Virol. 2018 May 23. pii: JVI.00281-18. doi: 10.1128/JVI.00281.
    PubMed     Text format     Abstract available


  56. KANG ZH, Bricault CA, Borducchi EN, Stephenson KE, et al
    Similar epitope specificities of IgG and IgA antibodies elicited by Ad26 vector prime, Env protein boost immunizations in rhesus monkeys.
    J Virol. 2018 May 23. pii: JVI.00537-18. doi: 10.1128/JVI.00537.
    PubMed     Text format     Abstract available


  57. BAIYEGUNHI O, Ndlovu B, Ogunshola F, Ismail N, et al
    Frequencies of circulating Th1-biased T follicular helper cells in acute HIV-1 infection correlate with the development of HIV-specific antibody responses and lower set point viral load.
    J Virol. 2018 May 23. pii: JVI.00659-18. doi: 10.1128/JVI.00659.
    PubMed     Text format     Abstract available


  58. CAREY BD, Ammosova T, Pinkham C, Lin X, et al
    Protein Phosphatase 1alpha Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.
    J Virol. 2018 May 16. pii: JVI.02068-17. doi: 10.1128/JVI.02068.
    PubMed     Text format     Abstract available


  59. KUMAR S, Morrison JH, Dingli D, Poeschla E, et al
    HIV-1 activation of innate immunity depends strongly on the intracellular level of TREX1 and sensing of incomplete reverse transcription products.
    J Virol. 2018 May 16. pii: JVI.00001-18. doi: 10.1128/JVI.00001.
    PubMed     Text format     Abstract available


  60. JI S, Na L, Ren H, Wang Y, et al
    Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
    J Virol. 2018 May 9. pii: JVI.00499-18. doi: 10.1128/JVI.00499.
    PubMed     Text format     Abstract available


  61. ELSAYED H, Nabi G, McKinstry WJ, Khoo KK, et al
    Intrastructural Help: Harnessing T-Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines.
    J Virol. 2018 May 9. pii: JVI.00141-18. doi: 10.1128/JVI.00141.
    PubMed     Text format     Abstract available


  62. QIAO J, Cao Y, Zabaleta J, Yang L, et al
    Regulation of virus-associated lymphoma growth and gene expression by bacterial quorum sensing molecules.
    J Virol. 2018 May 9. pii: JVI.00478-18. doi: 10.1128/JVI.00478.
    PubMed     Text format     Abstract available


  63. SCINTO HB, Gupta S, Thorat S, Mukhtar MM, et al
    A novel strategy to adapt SHIV-E1 carrying env from an RV144 volunteer to rhesus macaques: coreceptor switch and final recovery of a pathogenic virus with exclusive R5 tropism.
    J Virol. 2018 May 9. pii: JVI.02222-17. doi: 10.1128/JVI.02222.
    PubMed     Text format     Abstract available


  64. LODERMEYER V, Ssebyatika G, Passos V, Ponnurangam A, et al
    The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species-Specific.
    J Virol. 2018 May 9. pii: JVI.00226-18. doi: 10.1128/JVI.00226.
    PubMed     Text format     Abstract available


  65. MUELLER N, Pasternak AO, Klaver B, Cornelissen M, et al
    The HIV-1 Tat protein enhances splicing at the major splice donor site.
    J Virol. 2018 May 9. pii: JVI.01855-17. doi: 10.1128/JVI.01855.
    PubMed     Text format     Abstract available


  66. WENSEL D, Sun Y, Davis J, Li Z, et al
    A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin.
    J Virol. 2018 May 9. pii: JVI.00421-18. doi: 10.1128/JVI.00421.
    PubMed     Text format     Abstract available


  67. MAHDI M, Szojka Z, Motyan JA, Tozser J, et al
    Inhibitory effects of HIV-2 Vpx on replication of HIV-1.
    J Virol. 2018 May 9. pii: JVI.00554-18. doi: 10.1128/JVI.00554.
    PubMed     Text format     Abstract available


  68. PALESCH D, Bosinger SE, Mavigner M, Billingsley JM, et al
    Short-term pIFN-alpha2a treatment does not significantly reduce the viral reservoir of SIV-infected, ART-treated rhesus macaques.
    J Virol. 2018 May 2. pii: JVI.00279-18. doi: 10.1128/JVI.00279.
    PubMed     Text format     Abstract available


  69. BROZY J, Schlaepfer E, Mueller CKS, Rochat MA, et al
    Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager (BiTE(R)) Antibody Constructs.
    J Virol. 2018 May 2. pii: JVI.00491-18. doi: 10.1128/JVI.00491.
    PubMed     Text format     Abstract available


  70. HOUZET L, Perez-Losada M, Matusali G, Deleage C, et al
    Seminal SIV in chronically-infected cynomolgus macaques is dominated by virus originating from multiple genital organs.
    J Virol. 2018 May 2. pii: JVI.00133-18. doi: 10.1128/JVI.00133.
    PubMed     Text format     Abstract available


  71. ANTHONY C, York T, Bekker V, Matten D, et al
    Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope".
    J Virol. 2018;92.
    PubMed     Text format    


    April 2018
  72. MARTIN JL, Mendonca L, Marusinec R, Zuczek J, et al
    Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
    J Virol. 2018 Apr 25. pii: JVI.00333-18. doi: 10.1128/JVI.00333.
    PubMed     Text format     Abstract available


  73. OZOROWSKI G, Cupo A, Golabek M, LoPiccolo M, et al
    Effects of adjuvants on HIV-1 envelope glycoprotein SOSIP trimers in vitro.
    J Virol. 2018 Apr 18. pii: JVI.00381-18. doi: 10.1128/JVI.00381.
    PubMed     Text format     Abstract available


  74. PAPARISTO E, Woods MW, Coleman MD, Moghadasi SA, et al
    Evolution-guided structural and functional analyses of the HERC family reveals an ancient marine origin and determinants of antiviral activity.
    J Virol. 2018 Apr 18. pii: JVI.00528-18. doi: 10.1128/JVI.00528.
    PubMed     Text format     Abstract available


  75. PREVOST J, Richard J, Medjahed H, Alexander A, et al
    Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and ADCC responses.
    J Virol. 2018 Apr 18. pii: JVI.00484-18. doi: 10.1128/JVI.00484.
    PubMed     Text format     Abstract available


  76. BRICAULT CA, Kovacs JM, Badamchi-Zadeh A, McKee K, et al
    Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
    J Virol. 2018 Apr 11. pii: JVI.00369-18. doi: 10.1128/JVI.00369.
    PubMed     Text format     Abstract available


  77. REZAEI SD, Lu HK, Chang JJ, Rhodes A, et al
    The pathway to establishing HIV latency is critical to how latency is maintained and reversed.
    J Virol. 2018 Apr 11. pii: JVI.02225-17. doi: 10.1128/JVI.02225.
    PubMed     Text format     Abstract available


  78. POLICICCHIO BB, Cardozo EF, Sette P, Xu C, et al
    The dynamics of SIV 2-LTR Circles in the Presence and Absence of CD8(+) Cells.
    J Virol. 2018 Apr 11. pii: JVI.02100-17. doi: 10.1128/JVI.02100.
    PubMed     Text format     Abstract available


  79. LUO X, Yang W, Gao G
    SUN1 regulates HIV-1 nuclear import in a manner dependent on the interaction between the viral capsid and cellular cyclophilin A.
    J Virol. 2018 Apr 11. pii: JVI.00229-18. doi: 10.1128/JVI.00229.
    PubMed     Text format     Abstract available


  80. DELUCIA DC, Rinaldo CR, Rappocciolo G
    Inefficient HIV-1 trans infection of CD4(+) T cells by macrophages from HIV-1 nonprogressors is associated with altered membrane cholesterol and DC-SIGN.
    J Virol. 2018 Apr 11. pii: JVI.00092-18. doi: 10.1128/JVI.00092.
    PubMed     Text format     Abstract available


  81. NING J, Zhong Z, Fischer DK, Harris G, et al
    Truncated CPSF6 forms higher order complexes that bind and disrupt HIV-1 capsid.
    J Virol. 2018 Apr 11. pii: JVI.00368-18. doi: 10.1128/JVI.00368.
    PubMed     Text format     Abstract available


  82. NATESAMPILLAI S, Cummins NW, Nie Z, Sampath R, et al
    The proapoptotic, HIV protease generated Casp8p41 when bound and inactivated by Bcl2, is degraded by the proteasome.
    J Virol. 2018 Apr 11. pii: JVI.00037-18. doi: 10.1128/JVI.00037.
    PubMed     Text format     Abstract available


  83. BOYER PL, Smith SJ, Zhao XZ, Das K, et al
    Developing and evaluating inhibitors against the RNase H active site of HIV-1 RT.
    J Virol. 2018 Apr 11. pii: JVI.02203-17. doi: 10.1128/JVI.02203.
    PubMed     Text format     Abstract available


  84. WANG J, Shaban NM, Land AM, Brown WL, et al
    SIVmac239 Vif and Human APOBEC3B Interactions Resemble Those Between HIV-1 Vif and Human APOBEC3G.
    J Virol. 2018 Apr 4. pii: JVI.00447-18. doi: 10.1128/JVI.00447.
    PubMed     Text format     Abstract available


  85. SHENOY A, Dwork A, Elkind MSV, Marshall R, et al
    Brain large artery lymphocytic inflammation and Human Immunodeficiency Virus-related brain arterial remodeling.
    J Virol. 2018 Apr 4. pii: JVI.00081-18. doi: 10.1128/JVI.00081.
    PubMed     Text format     Abstract available


  86. MOYO T, Ereno-Orbea J, Jacob RA, Pavillet CE, et al
    Molecular basis of unusually high neutralization resistance in tier 3 HIV-1 strain 253-11.
    J Virol. 2018 Apr 4. pii: JVI.02261-17. doi: 10.1128/JVI.02261.
    PubMed     Text format     Abstract available


  87. CASTILLO-MENENDEZ LR, Witt K, Espy N, Princiotto A, et al
    Comparison of Uncleaved and Mature Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimers.
    J Virol. 2018 Apr 4. pii: JVI.00277-18. doi: 10.1128/JVI.00277.
    PubMed     Text format     Abstract available


    March 2018
  88. FETZER I, Gardner MR, Davis-Gardner ME, Prasad NR, et al
    eCD4-Ig variants that more potently neutralize HIV-1.
    J Virol. 2018 Mar 28. pii: JVI.02011-17. doi: 10.1128/JVI.02011.
    PubMed     Text format     Abstract available


  89. STRONGIN Z, Sharaf R, VanBelzen DJ, Jacobson JM, et al
    EFFECT OF SHORT-TERM ART INTERRUPTION ON LEVELS OF INTEGRATED HIV DNA.
    J Virol. 2018 Mar 28. pii: JVI.00285-18. doi: 10.1128/JVI.00285.
    PubMed     Text format     Abstract available


  90. HARKER JA, Wong KA, Dallari S, Bao P, et al
    IL-27R signalling mediates early viral containment and impacts innate and adaptive immunity after chronic lymphocytic choriomeningitis virus infection.
    J Virol. 2018 Mar 28. pii: JVI.02196-17. doi: 10.1128/JVI.02196.
    PubMed     Text format     Abstract available


  91. SALGADO M, Garcia-Minambres A, Dalmau J, Jimenez-Moyano E, et al
    Control of HIV-1 pathogenesis in viremic nonprogressors is independent of Gag-specific CTL responses.
    J Virol. 2018 Mar 28. pii: JVI.00346-18. doi: 10.1128/JVI.00346.
    PubMed     Text format     Abstract available


  92. GARRIDO C, Abad-Fernandez M, Tuyishime M, Pollara JJ, et al
    IL-15 STIMULATED NATURAL KILLER CELLS CLEAR HIV-1 INFECTED CELLS FOLLOWING LATENCY REVERSAL EX VIVO.
    J Virol. 2018 Mar 28. pii: JVI.00235-18. doi: 10.1128/JVI.00235.
    PubMed     Text format     Abstract available


  93. HSU DC, Sunyakumthorn P, Wegner M, Schuetz A, et al
    Central Nervous System Inflammation and Infection During Early, Non-Accelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
    J Virol. 2018 Mar 21. pii: JVI.00222-18. doi: 10.1128/JVI.00222.
    PubMed     Text format     Abstract available


  94. CASCAJERO A, Rastrojo A, Diez-Fuertes F, Hernandez-Novoa B, et al
    Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    J Virol. 2018 Mar 21. pii: JVI.00390-18. doi: 10.1128/JVI.00390.
    PubMed     Text format     Abstract available


  95. HESSELL AJ, Shapiro MB, Powell R, Malherbe DC, et al
    Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges.
    J Virol. 2018 Mar 7. pii: JVI.02198-17. doi: 10.1128/JVI.02198.
    PubMed     Text format     Abstract available


  96. KRISTENSEN AB, Kent SJ, Parsons MS
    Contribution of NK cell education to both direct and anti-HIV-1 antibody-dependent NK cell functions.
    J Virol. 2018 Mar 7. pii: JVI.02146-17. doi: 10.1128/JVI.02146.
    PubMed     Text format     Abstract available


  97. SHI J, Xiong R, Zhou T, Su P, et al
    HIV-1 Nef antagonizes SERINC5 restriction by downregulation of SERINC5 via the endosome/lysosome system.
    J Virol. 2018 Mar 7. pii: JVI.00196-18. doi: 10.1128/JVI.00196.
    PubMed     Text format     Abstract available


    February 2018
  98. PANASIUK M, Rychlowski M, Derewonko N, Bienkowska-Szewczyk K, et al
    Tunneling nanotubes (TNT) as a novel route of cell-to-cell spread of herpesviruses.
    J Virol. 2018 Feb 28. pii: JVI.00090-18. doi: 10.1128/JVI.00090.
    PubMed     Text format     Abstract available


  99. HUAN C, Li Z, Ning S, Wang H, et al
    Long non-coding RNA uc002yug.2 activates HIV-1 latency through regulating mRNA level of various RUNX1 isoforms and increasing Tat expression.
    J Virol. 2018 Feb 28. pii: JVI.01844-17. doi: 10.1128/JVI.01844.
    PubMed     Text format     Abstract available


  100. CARNATHAN DG, Mackel JJ, Sweat SL, Enemuo CA, et al
    Intragastric administration of Lactobacillus plantarum and AT-2-inactivated SIV does not protect Indian rhesus macaques from intra-rectal SIV challenge nor reduce virus replication after transmission.
    J Virol. 2018 Feb 28. pii: JVI.02030-17. doi: 10.1128/JVI.02030.
    PubMed     Text format     Abstract available


  101. ASHOKKUMAR M, Aralaguppe SG, Tripathy SP, Hanna LE, et al
    Unique phenotypic characteristics of recently transmitted HIV-1 subtype C envelope glycoprotein gp120: Use of CXCR6 co-receptor by transmitted founder viruses.
    J Virol. 2018 Feb 28. pii: JVI.00063-18. doi: 10.1128/JVI.00063.
    PubMed     Text format     Abstract available


  102. REED JC, Westergreen N, Barajas BC, Ressler DTB, et al
    The formation of RNA granule-derived capsid assembly intermediates appears to be conserved between HIV-1 and the non-primate lentivirus FIV.
    J Virol. 2018 Feb 21. pii: JVI.01761-17. doi: 10.1128/JVI.01761.
    PubMed     Text format     Abstract available


  103. CARNATHAN D, Lawson B, Yu J, Patel K, et al
    Reduced chronic lymphocyte activation following Interferon-alpha blockade in the acute phase of SIV infection in rhesus macaques.
    J Virol. 2018 Feb 21. pii: JVI.01760-17. doi: 10.1128/JVI.01760.
    PubMed     Text format     Abstract available


  104. WANG C, Zhou H, Xue Y, Liang J, et al
    Epstein-Barr Virus Nuclear Antigen Leader protein co-activates EP300.
    J Virol. 2018 Feb 21. pii: JVI.02155-17. doi: 10.1128/JVI.02155.
    PubMed     Text format     Abstract available


  105. MADRID-ELENA N, Garcia-Bermejo ML, Serrano-Villar S, Diaz-de Santiago A, et al
    Maraviroc is associated with latent HIV-1 reactivation through NF-kappaB activation in resting CD4(+) T cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    J Virol. 2018 Feb 14. pii: JVI.01931-17. doi: 10.1128/JVI.01931.
    PubMed     Text format     Abstract available


  106. SAUNDERS KO, Santra S, Parks R, Yates NL, et al
    Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.
    J Virol. 2018 Feb 7. pii: JVI.02035-17. doi: 10.1128/JVI.02035.
    PubMed     Text format     Abstract available


  107. BIRYUKOV J, Meyers C
    Superinfection Exclusion between Two High-Risk Human Papillomavirus (HPV) Types During a Co-Infection.
    J Virol. 2018 Feb 7. pii: JVI.01993-17. doi: 10.1128/JVI.01993.
    PubMed     Text format     Abstract available


    January 2018
  108. CHEUNG KW, Wu T, Ho SF, Wong YC, et al
    alpha4beta7(+) CD4(+) effector/effector memory T cells differentiate into productively and latently infected central memory T cells by TGFbeta1 during HIV-1 infection.
    J Virol. 2018 Jan 31. pii: JVI.01510-17. doi: 10.1128/JVI.01510.
    PubMed     Text format     Abstract available


  109. YATES NL, deCamp AC, Korber BT, Liao HX, et al
    HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.
    J Virol. 2018 Jan 31. pii: JVI.01843-17. doi: 10.1128/JVI.01843.
    PubMed     Text format     Abstract available


  110. RUJAS E, Leaman DP, Insausti S, Ortigosa-Pascual L, et al
    FUNCTIONAL OPTIMIZATION OF BROADLY NEUTRALIZING HIV-1 ANTIBODY 10E8 BY PROMOTING MEMBRANE INTERACTIONS.
    J Virol. 2018 Jan 31. pii: JVI.02249-17. doi: 10.1128/JVI.02249.
    PubMed     Text format     Abstract available


  111. OVERBAUGH J
    Defining the barriers to women publishing in high-impact journals.
    J Virol. 2018 Jan 24. pii: JVI.02127-17. doi: 10.1128/JVI.02127.
    PubMed     Text format     Abstract available


  112. TORRENTS DE LA PENA A, de Taeye SW, Sliepen K, LaBranche CC, et al
    Immunogenicity in rabbits of SOSIP trimers from clades A, B and C, given individually, sequentially or in combinations.
    J Virol. 2018 Jan 24. pii: JVI.01957-17. doi: 10.1128/JVI.01957.
    PubMed     Text format     Abstract available


  113. SATHEESAN S, Li H, Burnett JC, Takahashi M, et al
    HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART.
    J Virol. 2018 Jan 17. pii: JVI.02118-17. doi: 10.1128/JVI.02118.
    PubMed     Text format     Abstract available


  114. ABNER E, Stoszko M, Zeng L, Chen HC, et al
    A new quinoline BRD4 inhibitor targets a distinct latent HIV-1 reservoir for re-activation from other 'shock' drugs.
    J Virol. 2018 Jan 17. pii: JVI.02056-17. doi: 10.1128/JVI.02056.
    PubMed     Text format     Abstract available


  115. PAN R, Qin Y, Banasik M, Lees W, et al
    Increased epitope complexity correlated with antibody affinity maturation and a novel binding mode revealed by structures of rabbit antibodies against the third variable loop (V3) of HIV-1 gp120.
    J Virol. 2018 Jan 17. pii: JVI.01894-17. doi: 10.1128/JVI.01894.
    PubMed     Text format     Abstract available


  116. ITA S, Hill AK, Lam EC, Dufort FJ, et al
    High-Resolution Sequencing of Viral Populations During Early SIV Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.
    J Virol. 2018 Jan 17. pii: JVI.01574-17. doi: 10.1128/JVI.01574.
    PubMed     Text format     Abstract available


  117. WU X, Liu Z, Ding X, Yu D, et al
    Mechanism of HIV-1 Resistance to an Electronically Constrained alpha-Helical Peptide Membrane Fusion Inhibitor.
    J Virol. 2018 Jan 10. pii: JVI.02044-17. doi: 10.1128/JVI.02044.
    PubMed     Text format     Abstract available


  118. MISRA A, Gleeson E, Wang W, Ye C, et al
    Glycosyl-phosphatidylinositol-Anchored Anti-HIV Env Single Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
    J Virol. 2018 Jan 10. pii: JVI.02080-17. doi: 10.1128/JVI.02080.
    PubMed     Text format     Abstract available


  119. ST GELAIS C, Kim SH, Maksimova VV, Buzovetsky O, et al
    A Cyclin-binding Motif in Human SAMHD1 Is Required for Its HIV-1 Restriction, dNTPase Activity, Tetramer Formation, and Efficient Phosphorylation.
    J Virol. 2018 Jan 10. pii: JVI.01787-17. doi: 10.1128/JVI.01787.
    PubMed     Text format     Abstract available


  120. EVANS EL 3RD, Becker JT, Fricke SL, Patel K, et al
    HIV-1 Vif's capacity to manipulate the cell cycle is species-specific.
    J Virol. 2018 Jan 10. pii: JVI.02102-17. doi: 10.1128/JVI.02102.
    PubMed     Text format     Abstract available


  121. WILLS S, Hwang KK, Liu P, Dennison SM, et al
    HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis.
    J Virol. 2018 Jan 10. pii: JVI.01552-17. doi: 10.1128/JVI.01552.
    PubMed     Text format     Abstract available


  122. ENDE Z, Deymier MJ, Claiborne DT, Prince JL, et al
    HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
    J Virol. 2018 Jan 10. pii: JVI.01633-17. doi: 10.1128/JVI.01633.
    PubMed     Text format     Abstract available


  123. BADAMCHI-ZADEH A, Tartaglia LJ, Abbink P, Bricault CA, et al
    Therapeutic efficacy of vectored PGT121 gene delivery in HIV-1-infected humanized mice.
    J Virol. 2018 Jan 10. pii: JVI.01925-17. doi: 10.1128/JVI.01925.
    PubMed     Text format     Abstract available


  124. ZAIKOS TD, Painter MM, Sebastian NT, Terry VH, et al
    Class 1-selective histone deacetylase inhibitors enhance HIV latency reversal while preserving the activity of HDAC isoforms necessary for maximal HIV gene expression.
    J Virol. 2018 Jan 3. pii: JVI.02110-17. doi: 10.1128/JVI.02110.
    PubMed     Text format     Abstract available


  125. HRABER P, Rademeyer C, Williamson C, Seaman MS, et al
    Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments".
    J Virol. 2017;92.
    PubMed     Text format    


    December 2017
  126. GU Q, Zhang Z, Gertzen CGW, Haussinger D, et al
    Identification of a conserved interface of HIV-1 and FIV Vifs with Cullin 5.
    J Virol. 2017 Dec 20. pii: JVI.01697-17. doi: 10.1128/JVI.01697.
    PubMed     Text format     Abstract available


  127. ZHOU R, Wang X, Liu H, Guo L, et al
    GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors.
    J Virol. 2017 Dec 20. pii: JVI.01720-17. doi: 10.1128/JVI.01720.
    PubMed     Text format     Abstract available


  128. LIANG R, Sun Y, Liu Y, Wang J, et al
    Major histocompatibility complex class I (FLA-E*01801) molecular structure in domestic cats demonstrates species-specific characteristics in presenting viral antigen peptides.
    J Virol. 2017 Dec 20. pii: JVI.01631-17. doi: 10.1128/JVI.01631.
    PubMed     Text format     Abstract available


  129. FRICKE T, Brandariz-Nunez A, Wang X, Smith AB 3rd, et al
    Correction for Fricke et al., "Human Cytosolic Extracts Stabilize the HIV-1 Core".
    J Virol. 2017;91.
    PubMed     Text format    


  130. JONES AT, Chamcha V, Kesavardhana S, Shen X, et al
    A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques.
    J Virol. 2017 Dec 13. pii: JVI.01796-17. doi: 10.1128/JVI.01796.
    PubMed     Text format     Abstract available


  131. MORGER D, Zosel F, Buhlmann M, Zuger S, et al
    The three-fold axis of the HIV-1 capsid lattice is the species-specific binding interface for TRIM5alpha.
    J Virol. 2017 Dec 13. pii: JVI.01541-17. doi: 10.1128/JVI.01541.
    PubMed     Text format     Abstract available


  132. CHIKATA T, Van Tran G, Murakoshi H, Akahoshi T, et al
    HLA class I-mediated HIV-1 control in Vietnamese infected with HIV-1 subtype A/E.
    J Virol. 2017 Dec 13. pii: JVI.01749-17. doi: 10.1128/JVI.01749.
    PubMed     Text format     Abstract available


  133. COHEN YZ, Lorenzi JCC, Seaman MS, Nogueira L, et al
    Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells.
    J Virol. 2017 Dec 13. pii: JVI.01883-17. doi: 10.1128/JVI.01883.
    PubMed     Text format     Abstract available


  134. SCHOUEST B, Weiler AM, Janaka SK, Myers TA, et al
    Maintenance of AP-2 Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.
    J Virol. 2017 Dec 13. pii: JVI.01822-17. doi: 10.1128/JVI.01822.
    PubMed     Text format     Abstract available


  135. QUALLS ZM, Choudhary A, Honnen W, Prattipati R, et al
    Identification of novel structural determinants in MW965 Env that regulate the neutralization phenotype and conformational masking potential of primary HIV-1 isolates.
    J Virol. 2017 Dec 13. pii: JVI.01779-17. doi: 10.1128/JVI.01779.
    PubMed     Text format     Abstract available


  136. PERNAS M, Tarancon-Diez L, Rodriguez-Gallego E, Gomez J, et al
    Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
    J Virol. 2017 Dec 6. pii: JVI.01805-17. doi: 10.1128/JVI.01805.
    PubMed     Text format     Abstract available


  137. KIRSCHMAN J, Qi M, Ding L, Hammonds J, et al
    HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment is Required for Particle Incorporation.
    J Virol. 2017 Dec 6. pii: JVI.01893-17. doi: 10.1128/JVI.01893.
    PubMed     Text format     Abstract available


  138. SATO K, Misawa N, Takeuchi JS, Kobayashi T, et al
    Experimental adaptive evolution of SIVcpz to pandemic HIV-1 using a humanized mouse model.
    J Virol. 2017 Dec 6. pii: JVI.01905-17. doi: 10.1128/JVI.01905.
    PubMed     Text format     Abstract available


  139. YOON CH, Kim SY, Byeon SE, Jeong Y, et al
    Correction for Yoon et al., "p53-Derived Host Restriction of HIV-1 Replication by Protein Kinase R-Mediated Tat Phosphorylation and Inactivation".
    J Virol. 2017;91.
    PubMed     Text format    


    November 2017
  140. DE VERNEUIL A, Migraine J, Mammano F, Molina JM, et al
    Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir.
    J Virol. 2017 Nov 29. pii: JVI.01684-17. doi: 10.1128/JVI.01684.
    PubMed     Text format     Abstract available


  141. WAGNER JM, Christensen DE, Bhattacharya A, Dawidziak DM, et al
    A general model for retroviral capsid pattern recognition by TRIM5 proteins.
    J Virol. 2017 Nov 29. pii: JVI.01563-17. doi: 10.1128/JVI.01563.
    PubMed     Text format     Abstract available


  142. ADLAND E, Hill M, Lavandier N, Csala A, et al
    DIFFERENTIAL IMMUNODOMINANCE HIERARCHY OF CD8+ T CELL RESPONSES IN HLA-B*27:05 AND B*27:02-MEDIATED CONTROL OF HIV-1 INFECTION.
    J Virol. 2017 Nov 22. pii: JVI.01685-17. doi: 10.1128/JVI.01685.
    PubMed     Text format     Abstract available


  143. CHAILLON A, Gianella S, Lada SM, Perez-Santiago J, et al
    Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
    J Virol. 2017 Nov 15. pii: JVI.01589-17. doi: 10.1128/JVI.01589.
    PubMed     Text format     Abstract available


  144. WHITE E, Wu F, Chertova E, Bess J, et al
    Truncating the Gp41 Cytoplasmic Tail of SIV Decreases Sensitivity to Neutralizing Antibodies without Increasing Envelope Content of Virions.
    J Virol. 2017 Nov 15. pii: JVI.01688-17. doi: 10.1128/JVI.01688.
    PubMed     Text format     Abstract available


  145. ELLIS-CONNELL AL, Balgeman AJ, Zarbock KR, Barry G, et al
    ALT-803 transiently reduces SIV replication in the absence of antiretroviral treatment.
    J Virol. 2017 Nov 8. pii: JVI.01748-17. doi: 10.1128/JVI.01748.
    PubMed     Text format     Abstract available


  146. PINKEVYCH M, Fennessey CM, Cromer D, Tolstrup M, et al
    Estimating initial viral levels during HIV/SIV reactivation from latency.
    J Virol. 2017 Nov 8. pii: JVI.01667-17. doi: 10.1128/JVI.01667.
    PubMed     Text format     Abstract available


  147. QUITADAMO B, Peters PJ, Repik A, O'Connell O, et al
    HIV-1 R5 macrophage-tropic envelope glycoprotein trimers bind CD4 with high affinity, while the CD4 binding site on non-macrophage-tropic, T- tropic R5 envelopes is occluded.
    J Virol. 2017 Nov 8. pii: JVI.00841-17. doi: 10.1128/JVI.00841.
    PubMed     Text format     Abstract available


  148. SOTO-NAVA M, Avila-Rios S, Valenzuela-Ponce H, Garcia-Morales C, et al
    Weaker HLA footprints on HIV in the unique and highly genetically admixed host population of Mexico.
    J Virol. 2017 Nov 1. pii: JVI.01128-17. doi: 10.1128/JVI.01128.
    PubMed     Text format     Abstract available


  149. MALHERBE DC, Mendy J, Vang L, Barnette PT, et al
    Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C SHIV Mucosal Challenge.
    J Virol. 2017 Nov 1. pii: JVI.01092-17. doi: 10.1128/JVI.01092.
    PubMed     Text format     Abstract available


  150. PAYNE EH, Ramalingam D, Fox DT, Klotman ME, et al
    Polyploidy And Mitotic Cell Death Are Two Distinct HIV-1 Vpr-Driven Outcomes In Renal Tubule Epithelial Cells.
    J Virol. 2017 Nov 1. pii: JVI.01718-17. doi: 10.1128/JVI.01718.
    PubMed     Text format     Abstract available


  151. ARACHCHIGE SP, Henke W, Pramanik A, Kalamvoki M, et al
    Analysis of Select HSV-1 Proteins for Restriction of Human Immunodeficiency Virus Type 1: The HSV-1 gM Protein Potently Restricts HIV-1 by Preventing the Intracellular Transport and Processing of Env gp160.
    J Virol. 2017 Nov 1. pii: JVI.01476-17. doi: 10.1128/JVI.01476.
    PubMed     Text format     Abstract available


    October 2017
  152. PAROLINI F, Biswas P, Serena M, Sironi F, et al
    Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity.
    J Virol. 2017 Oct 25. pii: JVI.01711-17. doi: 10.1128/JVI.01711.
    PubMed     Text format     Abstract available


  153. KASMAPOUR B, Kubsch T, Rand U, Eiz-Vesper B, et al
    Myeloid dendritic cells repress human cytomegalovirus gene expression and spread by releasing interferon-unrelated soluble antiviral factors.
    J Virol. 2017 Oct 18. pii: JVI.01138-17. doi: 10.1128/JVI.01138.
    PubMed     Text format     Abstract available


  154. YOUNG GR, Terry SN, Manganaro L, Cuesta-Dominguez A, et al
    HIV-1 infection of primary CD4+ T cells regulates the expression of specific HERV-K (HML-2) elements.
    J Virol. 2017 Oct 18. pii: JVI.01507-17. doi: 10.1128/JVI.01507.
    PubMed     Text format     Abstract available


  155. MWIMANZI F, Toyoda M, Mahiti M, Mann JK, et al
    Relative resistance of MHC-B to Nef-mediated downregulation is conserved among primate lentiviruses and influences antiviral T cell responses in HIV-1-infected individuals.
    J Virol. 2017 Oct 18. pii: JVI.01409-17. doi: 10.1128/JVI.01409.
    PubMed     Text format     Abstract available


  156. MCGUIRE EP, Fong Y, Toote C, Cunningham CK, et al
    HIV exposed infants vaccinated with a MF59/rgp120 vaccine have higher magnitude anti-V1V2 IgG responses than adults immunized with the same vaccine.
    J Virol. 2017 Oct 11. pii: JVI.01070-17. doi: 10.1128/JVI.01070.
    PubMed     Text format     Abstract available


  157. CROMER D, Pinkevych M, Rasmussen TA, Lewin SR, et al
    Modelling of anti-latency treatment in HIV; What is the optimal duration of anti-retroviral-free HIV remission?
    J Virol. 2017 Oct 11. pii: JVI.01395-17. doi: 10.1128/JVI.01395.
    PubMed     Text format     Abstract available


  158. PAINTER MM, Zaikos TD, Collins KL
    Quiescence promotes latent HIV infection and resistance to reactivation from latency with histone deacetylase inhibitors.
    J Virol. 2017 Oct 11. pii: JVI.01080-17. doi: 10.1128/JVI.01080.
    PubMed     Text format     Abstract available


  159. SHEN X, Basu R, Sawant S, Beaumont D, et al
    HIV-1 gp120 Protein and MVAgp140 Boost Immunogens Increase immunogenicity of a DNA/MVA HIV-1 Vaccine.
    J Virol. 2017 Oct 11. pii: JVI.01077-17. doi: 10.1128/JVI.01077.
    PubMed     Text format     Abstract available


  160. BRACQ L, Xie M, Lambele M, Vu LT, et al
    T cell-macrophage fusion triggers multinucleated giant cell formation for HIV-1 spreading.
    J Virol. 2017 Oct 4. pii: JVI.01237-17. doi: 10.1128/JVI.01237.
    PubMed     Text format     Abstract available


  161. GIFT SK, Leaman DP, Zhang L, Kim AS, et al
    Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex.
    J Virol. 2017 Oct 4. pii: JVI.01216-17. doi: 10.1128/JVI.01216.
    PubMed     Text format     Abstract available


    September 2017
  162. MARRAS F, Casabianca A, Bozzano F, Ascierto ML, et al
    Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.
    J Virol. 2017 Sep 27. pii: JVI.00647-17. doi: 10.1128/JVI.00647.
    PubMed     Text format     Abstract available


  163. FAUTEUX-DANIEL S, Larouche A, Calderon V, Boulais J, et al
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol. 2017 Sep 20. pii: JVI.01372-17. doi: 10.1128/JVI.01372.
    PubMed     Text format     Abstract available


  164. GALVIS AE, Fisher HE, Fan H, Camerini D, et al
    Conformational Changes in the 5' End of the HIV-1 Genome Dependent on the Debranching Enzyme DBR1 During Early Stages of Infection.
    J Virol. 2017 Sep 20. pii: JVI.01377-17. doi: 10.1128/JVI.01377.
    PubMed     Text format     Abstract available


  165. VALLE-CASUSO JC, Allouch A, David A, Lenzi GM, et al
    p21 restricts HIV-1 in monocyte-derived dendritic cells through the reduction of dNTP biosynthesis and regulation of SAMHD1 antiviral activity.
    J Virol. 2017 Sep 20. pii: JVI.01324-17. doi: 10.1128/JVI.01324.
    PubMed     Text format     Abstract available


  166. CONTRERAS-GALINDO RA, Dube D, Fujinaga K, Kaplan MH, et al
    Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors.
    J Virol. 2017 Sep 20. pii: JVI.01309-17. doi: 10.1128/JVI.01309.
    PubMed     Text format     Abstract available


  167. RIFE MAGALIS B, Nolan DJ, Autissier P, Burdo TH, et al
    Insights into the impact of CD8+ immune modulation on HIV evolutionary dynamics in distinct anatomical compartments using SIV-infected macaque models of AIDS progression.
    J Virol. 2017 Sep 20. pii: JVI.01162-17. doi: 10.1128/JVI.01162.
    PubMed     Text format     Abstract available


  168. BROCCA-COFANO E, Kuhrt D, Siewe B, Xu C, et al
    Pathogenic Correlates of the Simian Immunodeficiency Virus (SIV)-Associated B Cell Dysfunction.
    J Virol. 2017 Sep 20. pii: JVI.01051-17. doi: 10.1128/JVI.01051.
    PubMed     Text format     Abstract available


  169. BOMSEL M, Ganor Y
    Calcitonin gene-related peptide induces HIV-1 proteasomal degradation in mucosal Langerhans cells.
    J Virol. 2017 Sep 13. pii: JVI.01205-17. doi: 10.1128/JVI.01205.
    PubMed     Text format     Abstract available


  170. TEIGLER JE, Zelinskyy G, Eller MA, Bolton DL, et al
    Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
    J Virol. 2017 Sep 13. pii: JVI.01263-17. doi: 10.1128/JVI.01263.
    PubMed     Text format     Abstract available


  171. LITTWITZ-SALOMON E, Schimmer S, Dittmer U
    The dose of retroviral infection determines the induction of anti-viral NK cell responses.
    J Virol. 2017 Sep 13. pii: JVI.01122-17. doi: 10.1128/JVI.01122.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: